Michael Klagsbrun

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Anatomy

Physiology

Cell Division

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Aloui Zohra; Hoos Sylviane; Geretti Elena; Kharmachi Habib; Haumont Pierre Yves; Mejdoub Hafedh; Klagsbrun Michael; England Patrick; Gasmi Ammar
Novel svVEGF isoforms from Macrovipera lebetina venom interact with neuropilins.
Dudley Andrew C; Klagsbrun Michael
Tumor endothelial cells join the resistance.
Bondeva Tzvetanka; Rüster Christiane; Franke Sybille; Hammerschmid Elke; Klagsbrun Michael; Cohen Clemens D; Wolf Gunter
Advanced glycation end-products suppress neuropilin-1 expression in podocytes.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Michael Klagsbrun (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Aloui Zohra; Hoos Sylviane; Geretti Elena; Kharmachi Habib; Haumont Pierre Yves; Mejdoub Hafedh; Klagsbrun Michael; England Patrick; Gasmi Ammar
Novel svVEGF isoforms from Macrovipera lebetina venom interact with neuropilins.
Biochemical and biophysical research communications 2009;389(1):10-5.
2009: Dudley Andrew C; Klagsbrun Michael
Tumor endothelial cells join the resistance.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(15):4787-9.
2009: Bondeva Tzvetanka; Rüster Christiane; Franke Sybille; Hammerschmid Elke; Klagsbrun Michael; Cohen Clemens D; Wolf Gunter
Advanced glycation end-products suppress neuropilin-1 expression in podocytes.
Kidney international 2009;75(6):605-16.
2009: Dudley Andrew C; Klagsbrun Michael
Tumor endothelial cells have features of adult stem cells.
Cell cycle (Georgetown, Tex.) 2009;8(2):236-8.
2008: Kawamura Harukiyo; Li Xiujuan; Goishi Katsutoshi; van Meeteren Laurens A; Jakobsson Lars; Cébe-Suarez Stéphanie; Shimizu Akio; Edholm Dan; Ballmer-Hofer Kurt; Kjellén Lena; Klagsbrun Michael; Claesson-Welsh Lena
Neuropilin-1 in regulation of VEGF-induced activation of p38MAPK and endothelial cell organization.
Blood 2008;112(9):3638-49.
2008: Shimizu Akio; Mammoto Akiko; Italiano Joseph E; Pravda Elke; Dudley Andrew C; Ingber Donald E; Klagsbrun Michael
ABL2/ARG tyrosine kinase mediates SEMA3F-induced RhoA inactivation and cytoskeleton collapse in human glioma cells.
The Journal of biological chemistry 2008;283(40):27230-8.
2008: Dudley Andrew C; Khan Zia A; Shih Shou-Ching; Kang Soo-Young; Zwaans Bernadette M M; Bischoff Joyce; Klagsbrun Michael
Calcification of multipotent prostate tumor endothelium.
Cancer cell 2008;14(3):201-11.
2008: Ghosh Kaustabh; Thodeti Charles K; Dudley Andrew C; Mammoto Akiko; Klagsbrun Michael; Ingber Donald E
Tumor-derived endothelial cells exhibit aberrant Rho-mediated mechanosensing and abnormal angiogenesis in vitro.
Proceedings of the National Academy of Sciences of the United States of America 2008;105(32):11305-10.
2008: Dudley A C; Shih S-C; Cliffe A R; Hida K; Klagsbrun M
Attenuated p53 activation in tumour-associated stromal cells accompanies decreased sensitivity to etoposide and vincristine.
British journal of cancer 2008;99(1):118-25.
2008: Amin Dhara N; Bielenberg Diane R; Lifshits Eugene; Heymach John V; Klagsbrun Michael
Targeting EGFR activity in blood vessels is sufficient to inhibit tumor growth and is accompanied by an increase in VEGFR-2 dependence in tumor endothelial cells.
Microvascular research 2008;76(1):15-22.
2008: Klagsbrun Michael; Moses Marsha A
Obituary: M. Judah Folkman (1933-2008).
Nature 2008;451(7180):781.
2008: Bielenberg Diane R; Shimizu Akio; Klagsbrun Michael
Semaphorin-induced cytoskeletal collapse and repulsion of endothelial cells.
Methods in enzymology 2008;443():299-314.
2008: Geretti Elena; Shimizu Akio; Klagsbrun Michael
Neuropilin structure governs VEGF and semaphorin binding and regulates angiogenesis.
Angiogenesis 2008;11(1):31-9.
2007: Bielenberg Diane R; Klagsbrun Michael
Targeting endothelial and tumor cells with semaphorins.
Cancer metastasis reviews 2007;26(3-4):421-31.
2007: Bahary Nathan; Goishi Katsutoshi; Stuckenholz Carsten; Weber Gerhard; Leblanc Jocelyn; Schafer Christopher A; Berman Sarah S; Klagsbrun Michael; Zon Leonard I
Duplicate VegfA genes and orthologues of the KDR receptor tyrosine kinase family mediate vascular development in the zebrafish.
Blood 2007;110(10):3627-36.
2007: Geretti Elena; Shimizu Akio; Kurschat Peter; Klagsbrun Michael
Site-directed mutagenesis in the B-neuropilin-2 domain selectively enhances its affinity to VEGF165, but not to semaphorin 3F.
The Journal of biological chemistry 2007;282(35):25698-707.
2007: Geretti Elena; Klagsbrun Michael
Neuropilins: novel targets for anti-angiogenesis therapies.
Cell adhesion & migration 2007;1(2):56-61.
2006: Goishi Katsutoshi; Shimizu Akio; Najarro Gabriel; Watanabe Sumiko; Rogers Rick; Zon Leonard I; Klagsbrun Michael
AlphaA-crystallin expression prevents gamma-crystallin insolubility and cataract formation in the zebrafish cloche mutant lens.
Development (Cambridge, England) 2006;133(13):2585-93.
2006: Bielenberg Diane R; Pettaway Curtis A; Takashima Seiji; Klagsbrun Michael
Neuropilins in neoplasms: expression, regulation, and function.
Experimental cell research 2006;312(5):584-93.
2006: Amin Dhara N; Hida Kyoko; Bielenberg Diane R; Klagsbrun Michael
Tumor endothelial cells express epidermal growth factor receptor (EGFR) but not ErbB3 and are responsive to EGF and to EGFR kinase inhibitors.
Cancer research 2006;66(4):2173-80.
2006: Kurschat Peter; Bielenberg Diane; Rossignol-Tallandier Mireille; Stahl Andreas; Klagsbrun Michael
Neuron restrictive silencer factor NRSF/REST is a transcriptional repressor of neuropilin-1 and diminishes the ability of semaphorin 3A to inhibit keratinocyte migration.
The Journal of biological chemistry 2006;281(5):2721-9.
2005: Feldner Julia; Becker Thomas; Goishi Katsutoshi; Schweitzer Jörn; Lee Percy; Schachner Melitta; Klagsbrun Michael; Becker Catherina G
Neuropilin-1a is involved in trunk motor axon outgrowth in embryonic zebrafish.
Developmental dynamics : an official publication of the American Association of Anatomists 2005;234(3):535-49.
2005: Stahl Andreas; Wu Xiao; Wenger Andreas; Klagsbrun Michael; Kurschat Peter
Endothelial progenitor cell sprouting in spheroid cultures is resistant to inhibition by osteoblasts: a model for bone replacement grafts.
FEBS letters 2005;579(24):5338-42.
2005: Klagsbrun Michael; Eichmann Anne
A role for axon guidance receptors and ligands in blood vessel development and tumor angiogenesis.
Cytokine & growth factor reviews 2005;16(4-5):535-48.
2005: Wey J S; Gray M J; Fan F; Belcheva A; McCarty M F; Stoeltzing O; Somcio R; Liu W; Evans D B; Klagsbrun M; Gallick G E; Ellis L M
Overexpression of neuropilin-1 promotes constitutive MAPK signalling and chemoresistance in pancreatic cancer cells.
British journal of cancer 2005;93(2):233-41.
2005: Hida Kyoko; Klagsbrun Michael
A new perspective on tumor endothelial cells: unexpected chromosome and centrosome abnormalities.
Cancer research 2005;65(7):2507-10.
2005: Mamluk Roni; Klagsbrun Michael; Detmar Michael; Bielenberg Diane R
Soluble neuropilin targeted to the skin inhibits vascular permeability.
Angiogenesis 2005;8(3):217-27.
2004: Nishi Eiichiro; Klagsbrun Michael
Heparin-binding epidermal growth factor-like growth factor (HB-EGF) is a mediator of multiple physiological and pathological pathways.
Growth factors (Chur, Switzerland) 2004;22(4):253-60.
2004: Kutcher Matthew E; Klagsbrun Michael; Mamluk Roni
VEGF is required for the maintenance of dorsal root ganglia blood vessels but not neurons during development.
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2004;18(15):1952-4.
2004: Hida Kyoko; Hida Yasuhiro; Amin Dhara N; Flint Alan F; Panigrahy Dipak; Morton Cynthia C; Klagsbrun Michael
Tumor-associated endothelial cells with cytogenetic abnormalities.
Cancer research 2004;64(22):8249-55.
2004: Bielenberg Diane R; Hida Yasuhiro; Shimizu Akio; Kaipainen Arja; Kreuter Michael; Kim Caroline Choi; Klagsbrun Michael
Semaphorin 3F, a chemorepulsant for endothelial cells, induces a poorly vascularized, encapsulated, nonmetastatic tumor phenotype.
The Journal of clinical investigation 2004;114(9):1260-71.
2004: Bovenkamp Diane E; Goishi Katsutoshi; Bahary Nathan; Davidson Alan J; Zhou Yi; Becker Thomas; Becker Catherina G; Zon Leonard I; Klagsbrun Michael
Expression and mapping of duplicate neuropilin-1 and neuropilin-2 genes in developing zebrafish.
Gene expression patterns : GEP 2004;4(4):361-70.
2004: Parikh Alexander A; Fan Fan; Liu Wen Biao; Ahmad Syed A; Stoeltzing Oliver; Reinmuth Niels; Bielenberg Diane; Bucana Corazon D; Klagsbrun Michael; Ellis Lee M
Neuropilin-1 in human colon cancer: expression, regulation, and role in induction of angiogenesis.
The American journal of pathology 2004;164(6):2139-51.
2004: Park Pyong Woo; Foster Timothy J; Nishi Eiichiro; Duncan Sheila J; Klagsbrun Michael; Chen Ye
Activation of syndecan-1 ectodomain shedding by Staphylococcus aureus alpha-toxin and beta-toxin.
The Journal of biological chemistry 2004;279(1):251-8.
2004: Goishi Katsutoshi; Klagsbrun Michael
Vascular endothelial growth factor and its receptors in embryonic zebrafish blood vessel development.
Current topics in developmental biology 2004;62():127-52.
2003: Goishi Katsutoshi; Lee Percy; Davidson Alan J; Nishi Eiichiro; Zon Leonard I; Klagsbrun Michael
Inhibition of zebrafish epidermal growth factor receptor activity results in cardiovascular defects.
Mechanisms of development 2003;120(7):811-22.
2003: Iwamoto Ryo; Yamazaki Satoru; Asakura Masanori; Takashima Seiji; Hasuwa Hidetoshi; Miyado Kenji; Adachi Satoshi; Kitakaze Masafumi; Hashimoto Koji; Raab Gerhard; Nanba Daisuke; Higashiyama Shigeki; Hori Masatsugu; Klagsbrun Michael; Mekada Eisuke
Heparin-binding EGF-like growth factor and ErbB signaling is essential for heart function.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(6):3221-6.
2003: Bates Damien; Taylor G Ian; Minichiello Joe; Farlie Peter; Cichowitz Adam; Watson Nadine; Klagsbrun Michael; Mamluk Roni; Newgreen Donald F
Neurovascular congruence results from a shared patterning mechanism that utilizes Semaphorin3A and Neuropilin-1.
Developmental biology 2003;255(1):77-98.
2003: Rossignol Mireille; Pouysségur Jacques; Klagsbrun Michael
Characterization of the neuropilin-1 promoter; gene expression is mediated by the transcription factor Sp1.
Journal of cellular biochemistry 2003;88(4):744-57.
2002: Hospital Véronique; Nishi Eiichiro; Klagsbrun Michael; Cohen Paul; Seidah Nabil G; Prat Annik
The metalloendopeptidase nardilysin (NRDc) is potently inhibited by heparin-binding epidermal growth factor-like growth factor (HB-EGF).
The Biochemical journal 2002;367(Pt 1):229-38.
2002: Lee Percy; Goishi Katsutoshi; Davidson Alan J; Mannix Robert; Zon Leonard; Klagsbrun Michael
Neuropilin-1 is required for vascular development and is a mediator of VEGF-dependent angiogenesis in zebrafish.
Proceedings of the National Academy of Sciences of the United States of America 2002;99(16):10470-5.
2002: Jin Kunlin; Mao Xiao Ou; Sun Yunjuan; Xie Lin; Jin Lan; Nishi Eiichiro; Klagsbrun Michael; Greenberg David A
Heparin-binding epidermal growth factor-like growth factor: hypoxia-inducible expression in vitro and stimulation of neurogenesis in vitro and in vivo.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2002;22(13):5365-73.
2002: Mamluk Roni; Gechtman Ze'ev; Kutcher Matthew E; Gasiunas Nijole; Gallagher John; Klagsbrun Michael
Neuropilin-1 binds vascular endothelial growth factor 165, placenta growth factor-2, and heparin via its b1b2 domain.
The Journal of biological chemistry 2002;277(27):24818-25.
2002: Takashima Seiji; Kitakaze Masafumi; Asakura Masanori; Asanuma Hiroshi; Sanada Shoji; Tashiro Fumi; Niwa Hitoshi; Miyazaki Ji Jun-ichi; Hirota Seiichi; Kitamura Yukihiko; Kitsukawa Takashi; Fujisawa Hajime; Klagsbrun Michael; Hori Masatsugu
Targeting of both mouse neuropilin-1 and neuropilin-2 genes severely impairs developmental yolk sac and embryonic angiogenesis.
Proceedings of the National Academy of Sciences of the United States of America 2002;99(6):3657-62.
2002: Klagsbrun Michael; Takashima Seiji; Mamluk Roni
The role of neuropilin in vascular and tumor biology.
Advances in experimental medicine and biology 2002;515():33-48.
2002: Kreuter M; Bielenberg D; Hida Y; Hida K; Klagsbrun M
Role of neuropilins and semaphorins in angiogenesis and cancer.
Annals of hematology 2002;81 Suppl 2():S74.
2002: Soker Shay; Miao Hua-Quan; Nomi Masashi; Takashima Seiji; Klagsbrun Michael
VEGF165 mediates formation of complexes containing VEGFR-2 and neuropilin-1 that enhance VEGF165-receptor binding.
Journal of cellular biochemistry 2002;85(2):357-68.
2001: Soker S; Kaefer M; Johnson M; Klagsbrun M; Atala A; Freeman M R
Vascular endothelial growth factor-mediated autocrine stimulation of prostate tumor cells coincides with progression to a malignant phenotype.
The American journal of pathology 2001;159(2):651-9.
2001: Nishi E; Prat A; Hospital V; Elenius K; Klagsbrun M
N-arginine dibasic convertase is a specific receptor for heparin-binding EGF-like growth factor that mediates cell migration.
The EMBO journal 2001;20(13):3342-50.
2001: Harper J; Gerstenfeld L C; Klagsbrun M
Neuropilin-1 expression in osteogenic cells: down-regulation during differentiation of osteoblasts into osteocytes.
Journal of cellular biochemistry 2001;81(1):82-92.
2000: Rossignol M; Gagnon M L; Klagsbrun M
Genomic organization of human neuropilin-1 and neuropilin-2 genes: identification and distribution of splice variants and soluble isoforms.
Genomics 2000;70(2):211-22.
2000: Miao H Q; Lee P; Lin H; Soker S; Klagsbrun M
Neuropilin-1 expression by tumor cells promotes tumor angiogenesis and progression.
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2000;14(15):2532-9.
2000: Kainulainen V; Sundvall M; Määttä J A; Santiestevan E; Klagsbrun M; Elenius K
A natural ErbB4 isoform that does not activate phosphoinositide 3-kinase mediates proliferation but not survival or chemotaxis.
The Journal of biological chemistry 2000;275(12):8641-9.
2000: Halder J B; Zhao X; Soker S; Paria B C; Klagsbrun M; Das S K; Dey S K
Differential expression of VEGF isoforms and VEGF(164)-specific receptor neuropilin-1 in the mouse uterus suggests a role for VEGF(164) in vascular permeability and angiogenesis during implantation.
Genesis (New York, N.Y. : 2000) 2000;26(3):213-24.
2000: Gagnon M L; Bielenberg D R; Gechtman Z; Miao H Q; Takashima S; Soker S; Klagsbrun M
Identification of a natural soluble neuropilin-1 that binds vascular endothelial growth factor: In vivo expression and antitumor activity.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(6):2573-8.
2000: Miao H Q; Klagsbrun M
Neuropilin is a mediator of angiogenesis.
Cancer metastasis reviews 2000;19(1-2):29-37.
1999: Gechtman Z; Alonso J L; Raab G; Ingber D E; Klagsbrun M
The shedding of membrane-anchored heparin-binding epidermal-like growth factor is regulated by the Raf/mitogen-activated protein kinase cascade and by cell adhesion and spreading.
The Journal of biological chemistry 1999;274(40):28828-35.
1999: Arbiser J L; Raab G; Rohan R M; Paul S; Hirschi K; Flynn E; Price E R; Fisher D E; Cohen C; Klagsbrun M
Isolation of mouse stromal cells associated with a human tumor using differential diphtheria toxin sensitivity.
The American journal of pathology 1999;155(3):723-9.
1999: Park J M; Adam R M; Peters C A; Guthrie P D; Sun Z; Klagsbrun M; Freeman M R
AP-1 mediates stretch-induced expression of HB-EGF in bladder smooth muscle cells.
The American journal of physiology 1999;277(2 Pt 1):C294-301.
1999: Makinen T; Olofsson B; Karpanen T; Hellman U; Soker S; Klagsbrun M; Eriksson U; Alitalo K
Differential binding of vascular endothelial growth factor B splice and proteolytic isoforms to neuropilin-1.
The Journal of biological chemistry 1999;274(30):21217-22.
1999: Miao H Q; Soker S; Feiner L; Alonso J L; Raper J A; Klagsbrun M
Neuropilin-1 mediates collapsin-1/semaphorin III inhibition of endothelial cell motility: functional competition of collapsin-1 and vascular endothelial growth factor-165.
The Journal of cell biology 1999;146(1):233-42.
1999: Rossignol M; Beggs A H; Pierce E A; Klagsbrun M
Human neuropilin-1 and neuropilin-2 map to 10p12 and 2q34, respectively.
Genomics 1999;57(3):459-60.
1999: Paria B C; Elenius K; Klagsbrun M; Dey S K
Heparin-binding EGF-like growth factor interacts with mouse blastocysts independently of ErbB1: a possible role for heparan sulfate proteoglycans and ErbB4 in blastocyst implantation.
Development (Cambridge, England) 1999;126(9):1997-2005.
1999: Elenius K; Choi C J; Paul S; Santiestevan E; Nishi E; Klagsbrun M
Characterization of a naturally occurring ErbB4 isoform that does not bind or activate phosphatidyl inositol 3-kinase.
Oncogene 1999;18(16):2607-15.
1999: Gagnon M L; Moy G K; Klagsbrun M
Characterization of the promoter for the human antisense fibroblast growth factor-2 gene; regulation by Ets in Jurkat T cells.
Journal of cellular biochemistry 1999;72(4):492-506.
1999: Klagsbrun M
Angiogenesis and cancer: AACR special conference in cancer research. American Association for Cancer Research.
Cancer research 1999;59(2):487-90.
1998: Giraudo E; Primo L; Audero E; Gerber H P; Koolwijk P; Soker S; Klagsbrun M; Ferrara N; Bussolino F
Tumor necrosis factor-alpha regulates expression of vascular endothelial growth factor receptor-2 and of its co-receptor neuropilin-1 in human vascular endothelial cells.
The Journal of biological chemistry 1998;273(34):22128-35.
1998: Dethlefsen S M; Raab G; Moses M A; Adam R M; Klagsbrun M; Freeman M R
Extracellular calcium influx stimulates metalloproteinase cleavage and secretion of heparin-binding EGF-like growth factor independently of protein kinase C.
Journal of cellular biochemistry 1998;69(2):143-53.
1998: Soker S; Takashima S; Miao H Q; Neufeld G; Klagsbrun M
Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor.
Cell 1998;92(6):735-45.
1998: Freeman M R; Paul S; Kaefer M; Ishikawa M; Adam R M; Renshaw A A; Elenius K; Klagsbrun M
Heparin-binding EGF-like growth factor in the human prostate: synthesis predominantly by interstitial and vascular smooth muscle cells and action as a carcinoma cell mitogen.
Journal of cellular biochemistry 1998;68(3):328-38.
1997: Raab G; Klagsbrun M
Heparin-binding EGF-like growth factor.
Biochimica et biophysica acta 1997;1333(3):F179-99.
1997: Suzuki M; Raab G; Moses M A; Fernandez C A; Klagsbrun M
Matrix metalloproteinase-3 releases active heparin-binding EGF-like growth factor by cleavage at a specific juxtamembrane site.
The Journal of biological chemistry 1997;272(50):31730-7.
1997: Soker S; Gollamudi-Payne S; Fidder H; Charmahelli H; Klagsbrun M
Inhibition of vascular endothelial growth factor (VEGF)-induced endothelial cell proliferation by a peptide corresponding to the exon 7-encoded domain of VEGF165.
The Journal of biological chemistry 1997;272(50):31582-8.
1997: Elenius K; Corfas G; Paul S; Choi C J; Rio C; Plowman G D; Klagsbrun M
A novel juxtamembrane domain isoform of HER4/ErbB4. Isoform-specific tissue distribution and differential processing in response to phorbol ester.
The Journal of biological chemistry 1997;272(42):26761-8.
1997: Elenius K; Paul S; Allison G; Sun J; Klagsbrun M
Activation of HER4 by heparin-binding EGF-like growth factor stimulates chemotaxis but not proliferation.
The EMBO journal 1997;16(6):1268-78.
1997: Freeman M R; Yoo J J; Raab G; Soker S; Adam R M; Schneck F X; Renshaw A A; Klagsbrun M; Atala A
Heparin-binding EGF-like growth factor is an autocrine growth factor for human urothelial cells and is synthesized by epithelial and smooth muscle cells in the human bladder.
The Journal of clinical investigation 1997;99(5):1028-36.
1996: Klagsbrun M; D'Amore P A
Vascular endothelial growth factor and its receptors.
Cytokine & growth factor reviews 1996;7(3):259-70.
1996: Riese D J; Kim E D; Elenius K; Buckley S; Klagsbrun M; Plowman G D; Stern D F
The epidermal growth factor receptor couples transforming growth factor-alpha, heparin-binding epidermal growth factor-like factor, and amphiregulin to Neu, ErbB-3, and ErbB-4.
The Journal of biological chemistry 1996;271(33):20047-52.
1996: Marikovsky M; Vogt P; Eriksson E; Rubin J S; Taylor W G; Joachim S; Klagsbrun M
Wound fluid-derived heparin-binding EGF-like growth factor (HB-EGF) is synergistic with insulin-like growth factor-I for Balb/MK keratinocyte proliferation.
The Journal of investigative dermatology 1996;106(4):616-21.
1996: Soker S; Fidder H; Neufeld G; Klagsbrun M
Characterization of novel vascular endothelial growth factor (VEGF) receptors on tumor cells that bind VEGF165 via its exon 7-encoded domain.
The Journal of biological chemistry 1996;271(10):5761-7.
1996: Gitay-Goren H; Cohen T; Tessler S; Soker S; Gengrinovitch S; Rockwell P; Klagsbrun M; Levi B Z; Neufeld G
Selective binding of VEGF121 to one of the three vascular endothelial growth factor receptors of vascular endothelial cells.
The Journal of biological chemistry 1996;271(10):5519-23.
1995: Freeman M R; Schneck F X; Gagnon M L; Corless C; Soker S; Niknejad K; Peoples G E; Klagsbrun M
Peripheral blood T lymphocytes and lymphocytes infiltrating human cancers express vascular endothelial growth factor: a potential role for T cells in angiogenesis.
Cancer research 1995;55(18):4140-5.
1995: Chen X; Raab G; Deutsch U; Zhang J; Ezzell R M; Klagsbrun M
Induction of heparin-binding EGF-like growth factor expression during myogenesis. Activation of the gene by MyoD and localization of the transmembrane form of the protein on the myotube surface.
The Journal of biological chemistry 1995;270(31):18285-94.
1995: Peoples G E; Blotnick S; Takahashi K; Freeman M R; Klagsbrun M; Eberlein T J
T lymphocytes that infiltrate tumors and atherosclerotic plaques produce heparin-binding epidermal growth factor-like growth factor and basic fibroblast growth factor: a potential pathologic role.
Proceedings of the National Academy of Sciences of the United States of America 1995;92(14):6547-51.
1995: Moses M A; Klagsbrun M; Shing Y
The role of growth factors in vascular cell development and differentiation.
International review of cytology 1995;161():1-48.
1994: no M; Raab G; Lau K; Abraham J A; Klagsbrun M
Purification and characterization of transmembrane forms of heparin-binding EGF-like growth factor.
The Journal of biological chemistry 1994;269(49):31315-21.
1994: Gallo R L; Ono M; Povsic T; Page C; Eriksson E; Klagsbrun M; Bernfield M
Syndecans, cell surface heparan sulfate proteoglycans, are induced by a proline-rich antimicrobial peptide from wounds.
Proceedings of the National Academy of Sciences of the United States of America 1994;91(23):11035-9.
1994: Raab G; Higashiyama S; Hetelekidis S; Abraham J A; Damm D; Ono M; Klagsbrun M
Biosynthesis and processing by phorbol ester of the cells surface-associated precursor form of heparin-binding EGF-like growth factor.
Biochemical and biophysical research communications 1994;204(2):592-7.
1994: Blotnick S; Peoples G E; Freeman M R; Eberlein T J; Klagsbrun M
T lymphocytes synthesize and export heparin-binding epidermal growth factor-like growth factor and basic fibroblast growth factor, mitogens for vascular cells and fibroblasts: differential production and release by CD4+ and CD8+ T cells.
Proceedings of the National Academy of Sciences of the United States of America 1994;91(8):2890-94.
1993: Klagsbrun M; Soker S
VEGF/VPF: the angiogenesis factor found?
Current biology : CB 1993;3(10):699-702.
1993: Dluz S M; Higashiyama S; Damm D; Abraham J A; Klagsbrun M
Heparin-binding epidermal growth factor-like growth factor expression in cultured fetal human vascular smooth muscle cells. Induction of mRNA levels and secretion of active mitogen.
The Journal of biological chemistry 1993;268(24):18330-4.
1993: Marikovsky M; Breuing K; Liu P Y; Eriksson E; Higashiyama S; Farber P; Abraham J; Klagsbrun M
Appearance of heparin-binding EGF-like growth factor in wound fluid as a response to injury.
Proceedings of the National Academy of Sciences of the United States of America 1993;90(9):3889-93.
1992: Klagsbrun M
Mediators of angiogenesis: the biological significance of basic fibroblast growth factor (bFGF)-heparin and heparan sulfate interactions.
Seminars in cancer biology 1992;3(2):81-7.
1992: Higashiyama S; Lau K; Besner G E; Abraham J A; Klagsbrun M
Structure of heparin-binding EGF-like growth factor. Multiple forms, primary structure, and glycosylation of the mature protein.
The Journal of biological chemistry 1992;267(9):6205-12.
1991: Klagsbrun M
Regulators of angiogenesis: stimulators, inhibitors, and extracellular matrix.
Journal of cellular biochemistry 1991;47(3):199-200.
1991: Weich H A; Iberg N; Klagsbrun M; Folkman J
Transcriptional regulation of basic fibroblast growth factor gene expression in capillary endothelial cells.
Journal of cellular biochemistry 1991;47(2):158-64.
1991: Klagsbrun M; Baird A
A dual receptor system is required for basic fibroblast growth factor activity.
Cell 1991;67(2):229-31.
1991: Kandel J; Bossy-Wetzel E; Radvanyi F; Klagsbrun M; Folkman J; Hanahan D
Neovascularization is associated with a switch to the export of bFGF in the multistep development of fibrosarcoma.
Cell 1991;66(6):1095-104.
1991: Powell P P; Klagsbrun M
Three forms of rat basic fibroblast growth factor are made from a single mRNA and localize to the nucleus.
Journal of cellular physiology 1991;148(2):202-10.
1991: Powell P P; Finklestein S P; Dionne C A; Jaye M; Klagsbrun M
Temporal, differential and regional expression of mRNA for basic fibroblast growth factor in the developing and adult rat brain.
Brain research. Molecular brain research 1991;11(1):71-7.
1991: Yayon A; Klagsbrun M; Esko J D; Leder P; Ornitz D M
Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor.
Cell 1991;64(4):841-8.
1991: Brigstock D R; Klagsbrun M
Subcellular distribution of multiple molecular weight forms of bFGF in hepatoma cells.
Annals of the New York Academy of Sciences 1991;638():427-30.
1991: Brigstock D R; Sasse J; Klagsbrun M
Subcellular distribution of basic fibroblast growth factor in human hepatoma cells.
Growth factors (Chur, Switzerland) 1991;4(3):189-96.
1990: Yayon A; Klagsbrun M
Autocrine regulation of cell growth and transformation by basic fibroblast growth factor.
Cancer metastasis reviews 1990;9(3):191-202.
1990: Klagsbrun M
The affinity of fibroblast growth factors (FGFs) for heparin; FGF-heparan sulfate interactions in cells and extracellular matrix.
Current opinion in cell biology 1990;2(5):857-63.
1990: Yayon A; Klagsbrun M
Autocrine transformation by chimeric signal peptide-basic fibroblast growth factor: reversal by suramin.
Proceedings of the National Academy of Sciences of the United States of America 1990;87(14):5346-50.
1990: Weich H A; Iberg N; Klagsbrun M; Folkman J
Expression of acidic and basic fibroblast growth factors in human and bovine vascular smooth muscle cells.
Growth factors (Chur, Switzerland) 1990;2(4):313-20.
1990: Brigstock D R; Klagsbrun M; Sasse J; Farber P A; Iberg N
Species-specific high molecular weight forms of basic fibroblast growth factor.
Growth factors (Chur, Switzerland) 1990;4(1):45-52.
1989: Iberg N; Rogelj S; Fanning P; Klagsbrun M
Purification of 18- and 22-kDa forms of basic fibroblast growth factor from rat cells transformed by the ras oncogene.
The Journal of biological chemistry 1989;264(33):19951-5.
1989: Rogelj S; Klagsbrun M; Atzmon R; Kurokawa M; Haimovitz A; Fuks Z; Vlodavsky I
Basic fibroblast growth factor is an extracellular matrix component required for supporting the proliferation of vascular endothelial cells and the differentiation of PC12 cells.
The Journal of cell biology 1989;109(2):823-31.
1989: Kurokawa M; Doctrow S R; Klagsbrun M
Neutralizing antibodies inhibit the binding of basic fibroblast growth factor to its receptor but not to heparin.
The Journal of biological chemistry 1989;264(13):7686-91.
1989: Rogelj S; Weinberg R A; Fanning P; Klagsbrun M
Characterization of tumors produced by signal peptide-basic fibroblast growth factor-transformed cells.
Journal of cellular biochemistry 1989;39(1):13-23.
1989: Shing Y; Klagsbrun M; Folkman J
A new method for purifying heparin-binding growth factors.
Annals of the New York Academy of Sciences 1989;556():166-72.
1988: Rogelj S; Weinberg R A; Fanning P; Klagsbrun M
Basic fibroblast growth factor fused to a signal peptide transforms cells.
Nature 1988;331(6152):173-5.
1988: Hannan R L; Kourembanas S; Flanders K C; Rogelj S J; Roberts A B; Faller D V; Klagsbrun M
Endothelial cells synthesize basic fibroblast growth factor and transforming growth factor beta.
Growth factors (Chur, Switzerland) 1988;1(1):7-17.
1987: Shing Y; Klagsbrun M
Purification and characterization of a bovine colostrum-derived growth factor.
Molecular endocrinology (Baltimore, Md.) 1987;1(5):335-8.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Michael Klagsbrun

Research Profile (preview)

Chemicals & Drugs

Living Beings

Concepts & Ideas

Disorders

Anatomy

Physiology

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Michael Klagsbrun (preview)

All Publications